Weiss Multi-Strategy Advisers’s Keryx Biopharmaceuticals Inc KERX Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2018
Q3 | – | Sell |
-67,929
| Closed | -$255K | – | 638 |
|
|
2018
Q2 | $255K | Buy |
67,929
+5,929
| +10% | +$22.3K | 0.01% | 409 |
|
|
2018
Q1 | $254K | Sell |
62,000
-2,000
| -3% | -$8.19K | 0.01% | 413 |
|
|
2017
Q4 | $298K | Hold |
64,000
| – | – | 0.01% | 417 |
|
|
2017
Q3 | $454K | Hold |
64,000
| – | – | 0.02% | 361 |
|
|
2017
Q2 | $463K | Sell |
64,000
-1,000
| -2% | -$7.23K | 0.02% | 390 |
|
|
2017
Q1 | $400K | Buy |
65,000
+1,000
| +2% | +$6.15K | 0.02% | 401 |
|
|
2016
Q4 | $375K | Hold |
64,000
| – | – | 0.02% | 305 |
|
|
2016
Q3 | $340K | Sell |
64,000
-1,610
| -2% | -$8.55K | 0.02% | 305 |
|
|
2016
Q2 | $434K | Sell |
65,610
-45,390
| -41% | -$300K | 0.03% | 292 |
|
|
2016
Q1 | $518K | Hold |
111,000
| – | – | 0.02% | 335 |
|
|
2015
Q4 | $561K | Hold |
111,000
| – | – | 0.04% | 256 |
|
|
2015
Q3 | $391K | Buy |
+111,000
| New | +$391K | 0.02% | 290 |
|
|
2015
Q2 | – | Hold |
0
| – | – | – | 524 |
|
|
2015
Q1 | – | Sell |
-10,000
| Closed | -$142K | – | 535 |
|
|
2014
Q4 | $142K | Buy |
+10,000
| New | +$142K | ﹤0.01% | 342 |
|
|
2014
Q1 | – | Sell |
-14,100
| Closed | -$183K | – | 1107 |
|
|
2013
Q4 | $183K | Buy |
+14,100
| New | +$183K | ﹤0.01% | 851 |
|